Thailand's home-grown Covid-19 vaccine to start production first quarter 2022

Image from The Nation Thailand/ANN

BANGKOK, Nov 20 (Bernama): Thailand’s Chulalongkorn University is expected to start the production of its mRNA Covid-19 vaccine, ChulaCov19, in the first quarter of next year.

Head of the Covid-19 vaccine development project Dr Kiat Ruxrungtham said ChulaCov19 will enter its third phase of human trials, with jabs scheduled to be administered in the first quarter of 2022 as well.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Thailand , Covid-19 , Vaccine , ChulaCov19 , mRNA


Next In Aseanplus News

Campaigning kicks off for presidential election
Group plans to ‘let 2 million dogs out’ near presidential office
Tunnel collapse a wake-up call for Modi’s infrastructure projects
Chinese navy ships arrive for joint drills
Kids driven to take perilous journey
Cow of high-end breed rakes in record �30.04mil at auction
Light at the end of the tunnel at last!
Couple marry next to body of bride’s father
‘Threat has gotten higher’
‘Beggars not torture victims’

Others Also Read